Table 1.

Deceased donor characteristics, stratified by AKI status

Characteristic		All (n=1304)	No AKI (n=1192)	AKI (n=112)	P Valuea
Age, yr		41±15	42±15	39±13	0.08
Male		787 (60)	719 (60)	68 (61)	0.94
Black race		208 (16)	186 (16)	22 (20)	0.27
Height, cm		171.17±10.8	171.1±10.9	171.81±9.68	0.70
Weight, kg		83.31±22.08	82.98±21.42	86.79±28.12	0.37
Hypertension		400 (31)	364 (31)	36 (32)	0.73
Diabetes		130 (10)	120 (10)	10 (9)	0.70
Cause of death	Stroke	429 (34)	396 (34)	33 (30)	0.11
	Anoxia	428 (34)	380 (33)	48 (44)
	Head trauma	397 (31)	368 (32)	29 (26)
	Other	18 (1)	18 (2)	0 (0)
Hepatitis C serostatus positive		48 (4)	43 (4)	5 (4)	0.60
Admission serum creatinine, mg/dl		1.1±0.61	1.1±0.6	1.02±0.64	0.01
Terminal serum creatinine, mg/dl		1.17±0.85	1.01±0.46	2.92±1.67	<0.001
Admission creatinine>terminal creatinine		625 (48)	625 (52)	0 (0)	<0.001
Extended criteria donor		246 (19)	226 (19)	20 (18)	0.78
Donation after circulatory determination of death		206 (16)	193 (16)	13 (12)	0.20
KDRI		1.29±0.41	1.28±0.42	1.36±0.36	0.01
KDPI, %		48.3±27.3	47.7±27.7	54.5±22.0	0.01
Kidneys transplanted	1	167 (13)	139 (12)	28 (25)	<0.001
	2	1137 (87)	1053 (88)	84 (75)
Total organs transplanted	1	60 (5)	48 (4)	12 (11)	0.05
	2	330 (25)	300 (25)	30 (27)
	3	410 (31)	374 (31)	36 (32)
	4	282 (22)	262 (22%)	20 (18)
	5	145 (11)	136 (11%)	9 (8)
	6	72 (6)	67 (6%)	5 (4)
	7	5 (0)	5 (0%)	0 (0)

Values reported are mean±SD, n (%), or as otherwise indicated. AKI was defined as at least a 2-fold increase in donor serum creatinine from the admission to terminal value.

^aWilcoxon rank-sum test for continuous variables and chi-squared or Fisher exact test for categorical variables.